For years now, scientists have tried to develop a safe and effective dengue vaccine. The challenge however, is that there are ...

Most people who contract dengue don't get sick. But in some people symptoms are severe: bleeding from the nose or mouth, ...

India has reached the 50 per cent enrolment mark in its first phase III clinical trial for the indigenous tetravalent dengue ...

Japan-based Takeda Pharmaceuticals, manufacturer of the second-generation dengue vaccine Qdenga, said it is just waiting for ...

ICMR and Panacea Biotec aim to finish enrollment for Phase 3 trials of India’s first indigenous dengue vaccine by October ...

Department of Health Secretary Teodoro Herbosa said the government was evaluating whether to introduce the Qdenga vaccine in ...

Although general awareness about dengue has improved, according to experts, a significant portion of the population remains ...

Takeda Healthcare Philippines on Thursday said that its voluntary withdrawal of its dengue applications in the US and Singapore has something to do with requested data collection. Takeda, a Japanese ...

The Food and Drug Administration (FDA) said Tuesday they are still processing the approval of vaccines intended to counter ...

A new study shows that Aedes aegypti, the mosquito responsible for spreading dengue, yellow fever and Zika, can still find ...